Post-Herpetic Neuralgia



3VM for Treatment of Post Herpetic Neuralgia


Condition:   Neuralgia, Postherpetic
Interventions:   Drug: Experimental: 3VM1001 Cream;   Other: Placebo: 3VM1001 vehicle
Sponsor:   CDA Research Group, Inc.
Recruiting - verified April 2017


Effect of Early Use of Oxycodone During the Acute Phase of Herpes Zoster on Preventing Postherpetic Neuralgia


Conditions:   Herpes Zoster;   Post-herpetic Neuralgia
Interventions:   Drug: Oxycodone;   Drug: Gabapentin;   Drug: Famciclovir
Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting - verified April 2017


Involvement of Reorganization of Cerebral Functional Connectivity in the Process of Transition to Postherpetic Neuralgia


Condition:   Postherpetic Neuralgia
Intervention:  
Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting - verified December 2016


Dose Response Study of EMA401 in Patients With Post-herpetic Neuralgia (PHN)


Condition:   Post-herpetic Neuralgia
Interventions:   Drug: EMA401;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Not yet recruiting - verified May 2017


Regional-anaesthesiological Infiltration Techniques for the Management of Chronic Pain: a Retrospective Study


Conditions:   Chronic Pain;   Trigeminal Neuralgia;   Cluster Headache;   Post-Zoster Neuralgia;   Post Zoster Pain;   Neuropathic Pain
Intervention:   Procedure: regional-anaesthesiological infiltration
Sponsor:   Charite University, Berlin, Germany
Completed - verified February 2017


Bioequivalence Study of Two Formulations of Pregabalin CR(Controlled-release) Table 300 mg


Condition:   Healthy
Interventions:   Drug: GLA5PR GLARS-NF3 tablet 300mg;   Drug: GLA5PR GLARS-NF1 tablet 300mg
Sponsor:   GL Pharm Tech Corporation
Completed - verified April 2017


Bioequivalence Study of Two Formulations of Pregabalin CR (Controlled-release) Table 150 mg


Condition:   Healthy
Interventions:   Drug: GLA5PR GLARS-NF3 tablet 150mg;   Drug: GLA5PR GLARS-NF1 tablet 150mg
Sponsor:   GL Pharm Tech Corporation
Completed - verified April 2017


Comparison of the Efficacy of the Ultrasound With Fluoroscopy in Guidance of Lumbar Sympathetic Block


Conditions:   Complex Regional Pain Syndrome;   Postherpetic Neuralgia;   Diabetic Polyneuropathy;   Peripheral Neuropathy
Interventions:   Procedure: 24G intravenous route for Lumbar Sympathetic Block (LSB):;   Device: 15-cm Chiba needle for Lumbar Sympathetic Block (LSB);   Device: Ultrasound for Lumbar Sympathetic Block (LSB);   Device: Fluoroscope for Lumbar Sympathetic Block (LSB);   Drug: 10 ml of 0.25% levobupivacaine injection for LSB;   Procedure: Temperature measurement for Lumbar Sympathetic Block (LSB);   Procedure: Postprocedure care for LSB
Sponsor:   Seoul National University
Recruiting - verified June 2016


Efficacy and Safety of TRK-700 in Patient With Post-Herpetic Neuralgia


Condition:   Post-Herpetic Neuralgia
Interventions:   Drug: TRK-700;   Drug: Placebo
Sponsor:   Toray Industries, Inc
Active, not recruiting - verified May 2017


Transcranial Magnetic Stimulation for Facial Pain


Conditions:   Trigeminal Nerve Injuries;   Post-herpetic Neuralgia;   Facial Pain;   Nervus Intermedius Neuralgia
Intervention:   Device: transcranial magnetic stimulation
Sponsor:   University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified August 2016


DS-5565 Phase III Study for Renal Impairment in Japanese Subjects


Conditions:   Diabetic Peripheral Neuropathic Pain;   Post-herpetic Neuralgia
Intervention:   Drug: DS-5565
Sponsors:   Daiichi Sankyo Co., Ltd.;   CMIC Co, Ltd. Japan
Completed - verified April 2017


Efficacy and Safety of Pregabalin Sustained Release Tablet for Postherpetic Neuralgia


Condition:   Postherpetic Neuralgia
Interventions:   Drug: Placebo;   Drug: Pregabalin SR tablet 165mg/day;   Drug: Pregabalin SR tablet 330mg/day;   Drug: Pregabalin SR tablet 660mg/day
Sponsor:   Jiangsu HengRui Medicine Co., Ltd.
Recruiting - verified February 2016


Burden of Herpes Zoster and Post-herpetic Neuralgia Among People ≥ 50 Years Old in France


Condition:   Herpes Zoster
Intervention:   Other: Data collection
Sponsor:   GlaxoSmithKline
Active, not recruiting - verified May 2017


A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia


Conditions:   Shingles;   Herpes Zoster;   Postherpetic Neuralgia
Interventions:   Drug: FV-100;   Drug: valacyclovir
Sponsor:   ContraVir Pharmaceuticals, Inc.
Recruiting - verified June 2016


A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN)


Condition:   Postherpetic Neuralgia
Interventions:   Drug: TV-45070;   Drug: Placebo
Sponsor:   Teva Branded Pharmaceutical Products, R&D Inc.
Active, not recruiting - verified May 2017


DS-5565 Phase III Study for Post-herpetic Neuralgia


Condition:   Post-Herpetic Neuralgia
Interventions:   Drug: Placebo;   Drug: DS-5565
Sponsors:   Daiichi Sankyo Co., Ltd.;   SRL Medisearch Inc.;   Quintiles, Inc.
Active, not recruiting - verified November 2016


Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain


Conditions:   Peripheral Nerve Injury;   Postherpetic Neuralgia
Interventions:   Drug: CAPNP, 50 ug/cm2 capsaicin patch;   Drug: CAPNP, 100 ug/cm2 capsaicin patch;   Drug: 0.075% capsaicin cream;   Other: Placebo patch
Sponsor:   Samyang Biopharmaceuticals Corporation
Completed - verified September 2014


Association of Transcutaneous Electrical Nerve Stimulation and Hypnosis


Conditions:   Limbs Arthrosis;   Non Arthrosic Limbs Arthralgia;   Chronic Lomboradiculalgia;   Chronic Back Pain;   Cervical Radiculopathy;   Post-herpetic Neuralgia;   Post-surgical Peripheral Neuropathic Pain;   Post Trauma Neuropathic Pain;   Complex Regional Pain Syndrome Type I or II;   Tendinopathy
Interventions:   Behavioral: Transcutaneous electrical nerve stimulation;   Behavioral: Transcutaneous electrical nerve stimulation and hypnosis
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting - verified June 2016


Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve


Condition:   Postherpetic Neuralgia
Interventions:   Drug: Civamide Nasal Spray;   Drug: Placebo
Sponsor:   Winston Laboratories
Terminated - verified January 2017


A Study to Assess the Burden of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged Sixty Years and Above


Condition:   Herpes Zoster
Intervention:   Other: Data collection
Sponsor:   GlaxoSmithKline
Completed - verified January 2017


Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in Italy


Condition:   Herpes Zoster
Intervention:   Other: Data collection
Sponsor:   GlaxoSmithKline
Recruiting - verified March 2017


Effects of Pennsaid on Clinical Neuropathic Pain


Conditions:   Neuralgia;   Postherpetic Neuralgia;   Reflex Sympathetic Dystrophy;   Complex Regional Pain Syndrome (CRPS)
Interventions:   Drug: Pennsaid;   Drug: Placebo (2.3% DMSO solution)
Sponsor:   Massachusetts General Hospital
Completed - verified December 2016


Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time


Condition:   Chronic Pain
Intervention:   Drug: Hydrocodone ER
Sponsor:   Teva Branded Pharmaceutical Products, R&D Inc.
Completed - verified February 2017


Acupuncture in Herpes Zoster Neuralgia (ACUZoster)


Conditions:   Herpes Zoster;   Postherpetic Neuralgia;   Pain
Interventions:   Device: Sham-laser acupuncture;   Drug: gabapentine;   Procedure: Acupuncture
Sponsor:   Dominik Irnich
Recruiting - verified February 2017


Evaluation of Civamide Patch in Treatment of Postherpetic Neuralgia and Post-Incisional Neuralgia


Condition:   Postherpetic Neuralgia
Intervention:   Drug: Civamide Patch
Sponsor:   Winston Laboratories
Completed - verified February 2017

Refine Your Search Advanced Search